Research

Energy balance

Sibutramine treatment (10-15 mg/day) for 1 year in obese patients with type 2 diabetes significantly improves glycemic control (HbA1c) and metabolic parameters (lipids, blood pressure) primarily through weight loss, independent of the drug's direct pharmacological effects.

If you are obese and have type 2 diabetes, adding sibutramine (10-15 mg daily) to a calorie-reduced diet and behavioral counseling can significantly lower your HbA1c and improve your lipid profile and blood pressure over a year. This benefit is largely due to the weight loss achieved, not just the drug's direct action. Consult your doctor to see if this is appropriate for you.

GoodSupportsHIGH confidence
Sibutramine treatment (10-15 mg/day) for 1 year in obese patients with type 2 diabetes significantly improves glycemic control (HbA1c) and metabolic parameters (lipids, blood pressure) primarily through weight loss, independent of the drug's direct pharmacological effects.
Ken Fujioka et al. · Diabetes Obesity and Metabolism · 2000

Why this rating

Randomized, double-blind, placebo-controlled trial with a substantial sample size (n=233) and a long duration (1 year).

Source

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

Ken Fujioka et al. · Diabetes Obesity and Metabolism · 2000

DOI 10.1046/j.1463-1326.2000.00081.x

rct · n=278Cited 244×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →